Lexicon Pharmaceuticals (LXRX) Gross Profit Growth (1y) (2017 - 2026)
Lexicon Pharmaceuticals (LXRX) Gross Profit Growth (1y) (2017 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
Gross Profit Growth (1y) (Qtr) |
| 1 |
Alterity Therapeutics |
925,601.88 Bn |
925,601.85 Bn |
- |
- |
| 2 |
Belite Bio |
58,560.00 Bn |
58,560.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
17,284.41 Bn |
17,284.40 Bn |
- |
- |
| 4 |
Legend Biotech |
2,809.00 Bn |
2,808.71 Bn |
242.10 Mn |
75.94% |
| 5 |
Evaxion A |
1,334.43 Bn |
1,334.42 Bn |
- |
- |
| 6 |
Akari Therapeutics |
1,312.27 Bn |
1,312.26 Bn |
- |
- |
| 7 |
Psyence Biomedical |
212.16 Bn |
212.16 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
114.83 Bn |
107.58 Bn |
2.59 Bn |
7.76% |
| 9 |
Abivax |
91.96 Bn |
91.96 Bn |
- |
- |
| 10 |
Lexicon Pharmaceuticals |
804.48 Mn |
633.82 Mn |
20.99 Mn |
1,604.06% |
| Date | Value |
|---|
| Mar 31, 2026 |
1,604.06% |
| Dec 31, 2025 |
-79.81% |
| Sep 30, 2025 |
744.07% |
| Jun 30, 2025 |
1,846.86% |
| Mar 31, 2025 |
16.01% |
| Dec 31, 2024 |
3,665.23% |
| Sep 30, 2024 |
983.23% |
| Jun 30, 2024 |
379.29% |
| Dec 31, 2021 |
98.80% |
| Jun 30, 2021 |
133.29% |
| Mar 31, 2021 |
-99.64% |
| Dec 31, 2020 |
-398.79% |
| Sep 30, 2020 |
-100.22% |
| Jun 30, 2020 |
-108.41% |
| Mar 31, 2020 |
294.01% |
| Dec 31, 2019 |
-51.81% |
| Sep 30, 2019 |
4,481.00% |
| Jun 30, 2019 |
-35.53% |
| Mar 31, 2019 |
-92.41% |
| Dec 31, 2018 |
-50.63% |
